About the study
Who are we
Wellington NZ first non-Swedish randomization
24 December 2017
First patient randomized in Wellington ICU, New Zealand. Congratulations!
18 December 2017
We have put together a short checklist for prognostication in the TTM2-trial. The checklist is available here and in the documents section.
Vanguard sites and protocol update 1.1
05 December 2017
In an initial phase of the TTM2-trial we have started randomisation at a few vanguard sites, to identifity any potential practical issues with randomisation...
TTM2 has started!
20 November 2017
Saturday the 18th Skåne University Hospital in Malmö randomised the first patient in the TTM2-trial! Congratulations and well done! Now we are off on an...
TTM2-trial soon to start
10 November 2017
After almost one year of planning we are delighted to announce that the TTM2-trial is soon ready to start in a selected group of vanguard sites. These sites...
New publication from TTM1 - Serum Tau
09 November 2017
Published in this month's Annals of Neurology, Niklas Mattsson and colleagues measured the neuronal protein tau as a predictor of neurological outcome after...
Post Cardiac Arrest Care Symposium in Lund, September 4-5 2017
19 May 2017
Welcome to the third international symposium on post cardiac arrest care focusing on neuroprognostication, cognitive follow-up, health-related quality-of-life...
Substudies - submit by April 30!
04 April 2017
Substudies in the TTM2-trial will be pre-defined analyses with separate protocols from the main study. As TTM2 is likely to be the largest trial to date on...
15 March 2017
Today we are launching our new TTM2 website. Our aim is for it to become an easy access point for everything pertaining to the TTM2-trial. All protocols, forms...
01 March 2017
The TTM2-project has received a grant from the Swedish Research Council (Vetenskapsrådet) for 2017-2020. With this grant we are now fully funded and have...